Urologic Design raises $1.2m to advance patented male incontinence device towards first human trial
Urologic Design has secured $1.2 million in pre-seed equity financing to advance a patented urethral occlusion device for men experiencing stress urinary incontinence. The company has completed prototype development and bench testing but must still establish safety, usability and effectiveness in its planned first human study.